79 related articles for article (PubMed ID: 3904399)
21. Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin.
Grem JL
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-8-S18-18. PubMed ID: 9420016
[TBL] [Abstract][Full Text] [Related]
22. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma].
Furuhata T; Hirata K; Yamamitsu S; Kimura H; Sasaki K; Hata F; Shirasaka T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1554-8. PubMed ID: 10553412
[TBL] [Abstract][Full Text] [Related]
24. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
25. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
26. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
Lokich JJ; Ahlgren JD; Gullo JJ; Philips JA; Fryer JG
J Clin Oncol; 1989 Apr; 7(4):425-32. PubMed ID: 2926468
[TBL] [Abstract][Full Text] [Related]
27. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
28. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
29. [Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer].
Yoshimura K; Hazama S; Iizuka N; Takano N; Matsuoka K; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2117-20. PubMed ID: 12484016
[TBL] [Abstract][Full Text] [Related]
30. [Low-dose CDDP and 5-FU for head and neck cancer patients].
Fujii M; Kanke M; Tomita T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
[TBL] [Abstract][Full Text] [Related]
31. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
[TBL] [Abstract][Full Text] [Related]
32. Phase I evaluation and pharmacokinetic study of weekly iv thymidine and 5-FU in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Chun H; Martin D; Young C
Cancer Treat Rep; 1985 Feb; 69(2):179-84. PubMed ID: 3971391
[TBL] [Abstract][Full Text] [Related]
33. Protracted low-dose cisplatin infusion in advanced colorectal cancer.
Lokich J; Zipoli T; Greene R; Paul S; Sonnenborn H; Moore C
Cancer Treat Rep; 1986 Apr; 70(4):523-4. PubMed ID: 3698046
[TBL] [Abstract][Full Text] [Related]
34. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.
Seifert P; Baker LH; Reed ML; Vaitkevicius VK
Cancer; 1975 Jul; 36(1):123-8. PubMed ID: 1203840
[TBL] [Abstract][Full Text] [Related]
35. [Continuous intra-arterial infusion chemotherapy by implantable catheter access connected with a continuous infusion pump].
Honda H; Agishi T; Nakazawa H; Teraoka S; Fuchinoue S; Nakagawa Y; Takahashi K; Ohta K
Gan No Rinsho; 1987 Oct; 33(12):1431-6. PubMed ID: 3682195
[TBL] [Abstract][Full Text] [Related]
36. Infusional 5-FU: historical evolution, rationale, and clinical experience.
Lokich J
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):19-22. PubMed ID: 9830620
[TBL] [Abstract][Full Text] [Related]
37. Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation.
Boublil JL; Milano G; Khater R; Bourry J; Thyss A; Bruneton JN; Renée N; Philip C; Namer M
Br J Cancer; 1985 Jul; 52(1):15-20. PubMed ID: 4015949
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of protracted venous infusion of 5-fluorouracil.
Lokich J; Bothe A; Fine N; Perri J
Cancer; 1981 Dec; 48(12):2565-8. PubMed ID: 7306915
[TBL] [Abstract][Full Text] [Related]
39. A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report.
Ansfield F; Klotz J; Nealon T; Ramirez G; Minton J; Hill G; Wilson W; Davis H; Cornell G
Cancer; 1977 Jan; 39(1):34-40. PubMed ID: 318916
[TBL] [Abstract][Full Text] [Related]
40. Cancer chemotherapy via ambulatory infusion pump.
Lokich JJ; Perri J; Bothe A; Zipoli T; Philips D; Sonneborn H; Paul S; Green R
Am J Clin Oncol; 1983 Jun; 6(3):355-63. PubMed ID: 6405610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
